GCGR and type 2 diabetes mellitus: However, as a therapy for T2DM, GCGR antagonists have shown undesirable AEs including elevated liver enzymes, accumulation of liver triglycerides, and hyperglucagonemia, which have discouraged further development of GCGR antagonists in this patient population.61